Rehg JE - Search Results

1

Differential effects of targeted disruption of thiopurine methyltransferase on mercaptopurine and thioguanine pharmacodynamics.

Hartford C, Vasquez E, Schwab M, Edick MJ, Rehg JE, Grosveld G, Pui CH, Evans WE, Relling MV. Hartford C, et al. Among authors: rehg je. Cancer Res. 2007 May 15;67(10):4965-72. doi: 10.1158/0008-5472.CAN-06-3508. Cancer Res. 2007. PMID: 17510427

2

Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Boulos N, Mulder HL, Calabrese CR, Morrison JB, Rehg JE, Relling MV, Sherr CJ, Williams RT. Boulos N, et al. Among authors: rehg je. Blood. 2011 Mar 31;117(13):3585-95. doi: 10.1182/blood-2010-08-301267. Epub 2011 Jan 24. Blood. 2011. PMID: 21263154 Free PMC article.

3

MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice.

Carella C, Bonten J, Rehg J, Grosveld GC. Carella C, et al. Leukemia. 2006 Sep;20(9):1582-92. doi: 10.1038/sj.leu.2404298. Epub 2006 Jun 29. Leukemia. 2006. PMID: 16810199

4

The ETS factor TEL2 is a hematopoietic oncoprotein.

Carella C, Potter M, Bonten J, Rehg JE, Neale G, Grosveld GC. Carella C, et al. Among authors: rehg je. Blood. 2006 Feb 1;107(3):1124-32. doi: 10.1182/blood-2005-03-1196. Epub 2005 Oct 18. Blood. 2006. PMID: 16234363 Free PMC article.

5

Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis.

Teitz T, Inoue M, Valentine MB, Zhu K, Rehg JE, Zhao W, Finkelstein D, Wang YD, Johnson MD, Calabrese C, Rubinstein M, Hakem R, Weiss WA, Lahti JM. Teitz T, et al. Among authors: rehg je. Cancer Res. 2013 Jul 1;73(13):4086-97. doi: 10.1158/0008-5472.CAN-12-2681. Epub 2013 Mar 27. Cancer Res. 2013. PMID: 23536557 Free PMC article.

6

Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient mice.

Eischen CM, Rehg JE, Korsmeyer SJ, Cleveland JL. Eischen CM, et al. Among authors: rehg je. Cancer Res. 2002 Apr 1;62(7):2184-91. Cancer Res. 2002. PMID: 11929842

7

Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors.

Zindy F, Uziel T, Ayrault O, Calabrese C, Valentine M, Rehg JE, Gilbertson RJ, Sherr CJ, Roussel MF. Zindy F, et al. Among authors: rehg je. Cancer Res. 2007 Mar 15;67(6):2676-84. doi: 10.1158/0008-5472.CAN-06-3418. Cancer Res. 2007. PMID: 17363588

8

Biochemical pharmacology of 2-chlorodeoxyadenosine in malignant human hematopoietic cell lines and therapeutic effects of 2-bromodeoxyadenosine in drug combinations in mice.

Avery TL, Rehg JE, Lumm WC, Harwood FC, Santana VM, Blakley RL. Avery TL, et al. Among authors: rehg je. Cancer Res. 1989 Sep 15;49(18):4972-8. Cancer Res. 1989. PMID: 2569929

9

Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null mice.

Zindy F, Nilsson LM, Nguyen L, Meunier C, Smeyne RJ, Rehg JE, Eberhart C, Sherr CJ, Roussel MF. Zindy F, et al. Among authors: rehg je. Cancer Res. 2003 Sep 1;63(17):5420-7. Cancer Res. 2003. PMID: 14500377

10

Biallelic Dicer1 Loss Mediated by aP2-Cre Drives Angiosarcoma.

Hanna JA, Drummond CJ, Garcia MR, Go JC, Finkelstein D, Rehg JE, Hatley ME. Hanna JA, et al. Among authors: rehg je. Cancer Res. 2017 Nov 15;77(22):6109-6118. doi: 10.1158/0008-5472.CAN-17-1262. Epub 2017 Sep 15. Cancer Res. 2017. PMID: 28916654 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page